Gritstone bio, Inc.
DelistedCIK 1656634fmd_19YMSYE74E635H57DQTBJBGP41Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2016 to Jun 30, 2024, 31 periods
Latest annual · FY2023
Millions- Total revenues
- 16
- Operating income
- (140)
- Net income
- (138)
- Free cash flow
- (126)
Latest quarter · Q2 FY2024
Millions- Total revenues
- 1
- Operating income
- (28)
- Net income
- (23)
- Free cash flow
- (27)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2020 to FY2023
- +59.4%
- Revenue, 5 yearsFY2018 to FY2023
- +69.0%
- Net income, 5 yearsFY2018 to FY2023
- n/m
Gritstone bio, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Revenue | $16.3 million | $19.9 million | -18.1% | 10-K 2024-03-05 · proof |
| Operating income | -$139.6 million | -$120.4 million | 10-K 2024-03-05 · proof | |
| Net income | -$138.5 million | -$119.7 million | 10-K 2024-03-05 · proof | |
| Cash from operating activities | -$121.6 million | -$115.9 million | 10-K 2024-03-05 · proof | |
| Free cash flow | -$126.2 million | -$121.8 million | 10-K 2024-03-05 · proof | |
| Total assets | $177.8 million | $240.8 million | -26.2% | 10-K 2024-03-05 · proof |
| Total liabilities | $125.9 million | $70 million | +80% | 10-K 2024-03-05 · proof |
| Cash and cash equivalents | $63 million | $55.5 million | +13.5% | 10-K 2024-03-05 · proof |
- What was Gritstone bio, Inc.'s revenue in fiscal 2023?
- Gritstone bio, Inc. reported revenue of $16.3 million for fiscal 2023 (the year ended Dec 31, 2023), against $19.9 million the year before (-18.1%). Source: the 10-K filed with the SEC on Mar 5, 2024. SEC
- What was Gritstone bio, Inc.'s operating income in fiscal 2023?
- Gritstone bio, Inc. reported operating income of -$139.6 million for fiscal 2023 (the year ended Dec 31, 2023), against -$120.4 million the year before. Source: the 10-K filed with the SEC on Mar 5, 2024. SEC
- What was Gritstone bio, Inc.'s net income in fiscal 2023?
- Gritstone bio, Inc. reported net income of -$138.5 million for fiscal 2023 (the year ended Dec 31, 2023), against -$119.7 million the year before. Source: the 10-K filed with the SEC on Mar 5, 2024. SEC
- What was Gritstone bio, Inc.'s cash from operating activities in fiscal 2023?
- Gritstone bio, Inc. reported cash from operating activities of -$121.6 million for fiscal 2023 (the year ended Dec 31, 2023), against -$115.9 million the year before. Source: the 10-K filed with the SEC on Mar 5, 2024. SEC
- What was Gritstone bio, Inc.'s free cash flow in fiscal 2023?
- Gritstone bio, Inc. reported free cash flow of -$126.2 million for fiscal 2023 (the year ended Dec 31, 2023), against -$121.8 million the year before. Source: the 10-K filed with the SEC on Mar 5, 2024. SEC
- What are Gritstone bio, Inc.'s total assets?
- As of Dec 31, 2023, Gritstone bio, Inc. reported total assets of $177.8 million, against $240.8 million a year earlier (-26.2%). Source: the 10-K filed with the SEC on Mar 5, 2024. SEC
- What are Gritstone bio, Inc.'s total liabilities?
- As of Dec 31, 2023, Gritstone bio, Inc. reported total liabilities of $125.9 million, against $70 million a year earlier (+80%). Source: the 10-K filed with the SEC on Mar 5, 2024. SEC
- What are Gritstone bio, Inc.'s cash and cash equivalents?
- As of Dec 31, 2023, Gritstone bio, Inc. reported cash and cash equivalents of $63 million, against $55.5 million a year earlier (+13.5%). Source: the 10-K filed with the SEC on Mar 5, 2024. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1656634&period_type=annual&limit=5"Information only, not investment advice.